A Search Service for Abbreviation / Long Form

â–  Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 389
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : TICs
Long Form : tumor-initiating cells
No. Year Title Co-occurring Abbreviation
2020 A perspective on challenges and opportunities in characterizing oral cancer stem cells. CSCs, EMT
2020 Cancer stem cells: A review from origin to therapeutic implications. CSCs
2020 Cell fate, metabolic reprogramming and lncRNA of tumor-initiating stem-like cells induced by alcohol. HCC
2020 Circ-SOX4 promotes non-small cell lung cancer progression by activating the Wnt/beta-catenin pathway. circRNAs, NSCLC
2020 Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids. HCC, PDO
2020 Hydrodynamic shear-based purification of cancer cells with enhanced tumorigenic potential. ---
2020 LGR5 marks targetable tumor-initiating cells in mouse liver cancer. CSCs
2020 microRNA-29a regulates liver tumor-initiating cells expansion via Bcl-2 pathway. HCC, miRNAs, PDXs
2020 microRNA-454 promotes liver tumor-initiating cell expansion by regulating SOCS6. HCC, PDXs
10  2020 miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance. Akt, HCC, miR, miRNAs, PDXs, PTEN
11  2020 Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features. CHC, HPC
12  2020 Nitroprusside induces melanoma ferroptosis with serum supplementation and prolongs survival under serum depletion or hypoxia. CSC, HIF-1alpha, NTI-D, SS
13  2020 NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma. HCC, SHH
14  2020 The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer. ALDH, CSCs, NSCLC
15  2020 Transcriptomic analysis reveals that BMP4 sensitizes glioblastoma tumor-initiating cells to mechanical cues. BMP4, GBM
16  2019 A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting Drugs. ---
17  2019 A Shifty Target: Tumor-Initiating Cells and Their Metabolism. ---
18  2019 Breast Cancer Stem Cells with Tumor- versus Metastasis-Initiating Capacities Are Modulated by TGFBR1 Inhibition. CSCs, TIP
19  2019 Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier. CSCs, NB
20  2019 circCTIC1 promotes the self-renewal of colon TICs through BPTF-dependent c-Myc expression. BPTF, NURF
21  2019 Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cells. ROS
22  2019 CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs). CDX, CSC, CTCs, EMT
23  2019 CXCL11 promotes self-renewal and tumorigenicity of alpha2delta1+ liver tumor-initiating cells through CXCR3/ERK1/2 signaling. HCC
24  2019 FOXD3 Suppresses Tumor-Initiating Features in Lung Cancer via Transcriptional Repression of WDR5. ---
25  2019 Hydrodynamic shear stress promotes epithelial-mesenchymal transition by downregulating ERK and GSK3beta activities. CSLCs, CTCs, EMT, ERK, GSK, MSC, NO, ROS
26  2019 Hypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells. CRC, CSCs, miRNA
27  2019 Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway. CRC, CSCs
28  2019 Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma. CR, MM, MRD, SP
29  2019 Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts. FACS, PDXs
30  2019 Labeling Cancer Stem Cells with 13C6 Glucose and 13C5 Glutamine for Metabolic Flux Analysis. CSCs
31  2019 Lysyl oxidase assists tumor‑initiating cells to enhance angiogenesis in hepatocellular carcinoma. ECM, LOX, VEGF
32  2019 Methionine is a metabolic dependency of tumor-initiating cells. ---
33  2019 MMP14 empowers tumor-initiating breast cancer cells under hypoxic nutrient-depleted conditions. EMT, iTIC, MMP14
34  2019 Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype. ER, HER2, PR, TNBC
35  2019 PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation. ESCC, PRMT1
36  2019 Similarities Between Embryo Development and Cancer Process Suggest New Strategies for Research and Therapy of Tumors: A New Point of View. CDCs, CPCs, CSCs, EMT, MET, p-ESCs, TGCs, TMCs
37  2019 The effect of transferrin-targeted, resveratrol-loaded liposomes on neurosphere cultures of glioblastoma: implications for targeting tumour-initiating cells. GBMs, NS, RES, Tf-RES-L
38  2019 Tumor suppressor miR-215 counteracts hypoxia-induced colon cancer stem cell activity. miRNA
39  2018 AhR ligand aminoflavone suppresses alpha6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells. AF, TamR
40  2018 Alterations of Signaling Pathways Related to the Immune System in Breast Cancer: New Perspectives in Patient Management. CSCs, Ir
41  2018 An improved method for culturing patient-derived colorectal cancer spheroids. bFGF, EGF, PD-CRC
42  2018 Analysis of Chromatin Opening in Heterochromatic Non-Small Cell Lung Cancer Tumor-Initiating Cells in Relation to DNA-Damaging Antitumor Treatment. HDACi, NSCLC
43  2018 Baicalein Targets GTPase-Mediated Autophagy to Eliminate Liver Tumor-Initiating Stem Cell-Like Cells Resistant to mTORC1 Inhibition. BC, HCC, mTORC1
44  2018 Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment. CSCs
45  2018 Emerging role of lipid metabolism alterations in Cancer stem cells. CSCs
46  2018 Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer. CRC, nRT, TRG
47  2018 EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours. TNBC
48  2018 Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer. ---
49  2018 Identification of Tumor Initiating Cells with a Small-Molecule Fluorescent Probe by Using Vimentin as a Biomarker. EMT
50  2018 Linc00210 drives Wnt/beta-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner. CNA, HCC
51  2018 Linking invasive motility to protein expression in single tumor cells. ---
52  2018 LncAPC drives Wnt/beta-catenin activation and liver TIC self-renewal through EZH2 mediated APC transcriptional inhibition. ---
53  2018 LncFZD6 initiates Wnt/beta-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation. ---
54  2018 LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner. GPCR
55  2018 LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation. HOX
56  2018 LncMAPK6 drives MAPK6 expression and liver TIC self-renewal. ---
57  2018 LncTIC1 interacts with beta-catenin to drive liver TIC self-renewal and liver tumorigenesis. lncRNAs
58  2018 miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1. miRNA, NSCLC, OS, PFS, TM4SF1
59  2018 Pluripotency transcription factors and Metabolic reprogramming of mitochondria in tumor-initiating stem-like cells. OXPHOS, TFs
60  2018 Role of Akt Isoforms Controlling Cancer Stem Cell Survival, Phenotype and Self-Renewal. CSC, EMT, PI3K
61  2018 Scalable Culturing of Primary Human Glioblastoma Tumor-Initiating Cells with a Cell-Friendly Culture System. ---
62  2018 Targeting molecular pathways in cancer stem cells by natural bioactive compounds. CSCs
63  2018 The long noncoding RNA lncZic2 drives the self-renewal of liver tumor-initiating cells via the protein kinase C substrates MARCKS and MARCKSL1. BRG1, lncRNA, MARCKS, MARCKSL1, Zic2
64  2017 A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions. ADC, NSCLC, OvCa, PDXs, PTK7, TNBC
65  2017 An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer. ---
66  2017 Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma. CSCs, ESCC, miR-455-3p, PDX, TGF-beta
67  2017 Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment. HCC
68  2017 BRCA1-IRIS overexpression promotes and maintains the tumor initiating phenotype: implications for triple negative breast cancer early lesions. EMT, IRISOE
69  2017 Buformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice. MEC, MRUs, RTK
70  2017 Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire? CSCs
71  2017 CD24, CD44 and EpCAM enrich for tumour-initiating cells in a newly established patient-derived xenograft of nasopharyngeal carcinoma. NPC
72  2017 Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence. cfDNA, IRAK1, S100A
73  2017 Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth. EMT, SP, TNBC
74  2017 DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells. CD, DHFR, MDR1, OS-TICs
75  2017 EMT programs promote basal mammary stem cell and tumor-initiating cell stemness by inducing primary ciliogenesis and Hedgehog signaling. EMT, Hh, MaSCs, MaTICs, SCs
76  2017 Existence of cancer stem cells in hepatocellular carcinoma: myth or reality? CC, CSC, HCC
77  2017 FAM83A is amplified and promotes cancer stem cell-like traits and chemoresistance in pancreatic cancer. CSCs, FAM83A, TGF-beta
78  2017 Gene expression profiling and construction of a putative gene regulatory network of bladder cancer tumor-initiating cells. ---
79  2017 Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells. PCK2, TCA
80  2017 High-frequency irreversible electroporation targets resilient tumor-initiating cells in ovarian cancer. H-FIRE, IRE, MOSE
81  2017 High-mobility-group protein 2 regulated by microRNA-127 and small heterodimer partner modulates pluripotency of mouse embryonic stem cells and liver tumor initiating cells. EB, ESCs, HMGB2, ICM
82  2017 Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERalpha- breast cancer. FFPE, GSEA, ROC
83  2017 Identification of tumor-initiating cells derived from two canine rhabdomyosarcoma cell lines. ---
84  2017 Immunomagnetic separation of tumor initiating cells by screening two surface markers. IMS
85  2017 Induced-Decay of Glycine Decarboxylase Transcripts as an Anticancer Therapeutic Strategy for Non-Small-Cell Lung Carcinoma. NSCLC, ORF, shAONs
86  2017 Inhibition of Cdk5 induces cell death of tumor-initiating cells. EMT, TMA
87  2017 Iron addiction: a novel therapeutic target in ovarian cancer. FPN, IL-6
88  2017 Isolation, identification, and characterization of cancer stem cells: A review. CSCs
89  2017 Methylparaben stimulates tumor initiating cells in ER+ breast cancer models. EDCs, mePB
90  2017 microRNA-143/145 loss induces Ras signaling to promote aggressive Pten-deficient basal-like breast cancer. ---
91  2017 MicroRNA-31 suppresses the self-renewal capability of alpha2delta1+ liver tumor-initiating cells by targeting ISL1. HCC, ISL1
92  2017 MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer. chr, LOH, PCa
93  2017 N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc. NDRG1, NSCLC
94  2017 Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer. CSCs, LSC
95  2017 SAMMSON drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/beta-catenin activation. ---
96  2017 Single cell time-lapse analysis reveals that podoplanin enhances cell survival and colony formation capacity of squamous cell carcinoma cells. ROCK
97  2017 Single tumor-initiating cells evade immune clearance by recruiting type II macrophages. TICAMs, YAP
98  2017 Small-sized colorectal cancer cells harbor metastatic tumor-initiating cells. CRC, FACS, FSC, YAP1
99  2017 Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6. HCC, HSCs, LRP5 and LRP6, mRNA, MUFAs, RAN1, SCD
100  2017 Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation. ER, HCCs, PDTX, SCD1